Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

1.9K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.9K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Engineering Biosensors to Enhance Monoterpene Indole Alkaloid Production in Yeast.

bioRxiv : the preprint server for biology·2026
Same author

Ligify 2.0: a web server for predicted small molecule biosensors.

Nucleic acids research·2026
Same author

Rational design of selective bispecific EPO-R/CD131 agonists.

Protein engineering, design & selection : PEDS·2025
Same author

groovDB in 2026: a community-editable database of small molecule biosensors.

Nucleic acids research·2025
Same author

A coronaviral pore-replicase complex links RNA synthesis and export from double-membrane vesicles.

Science advances·2024
Same author

Ten Years of the Synthetic Biology Summer Course at Cold Spring Harbor Laboratory.

ACS synthetic biology·2024
Same journal

A human-specific genetic modifier reconfigures large-scale cortical network dynamics underlying behavioral performance.

bioRxiv : the preprint server for biology·2026
Same journal

<i>Staphylococcus aureus</i> uses a eukaryotic-like uridyltransferase to make UDP-GlcNAc for cell wall synthesis.

bioRxiv : the preprint server for biology·2026
Same journal

Dynamic redistribution of eIF4F controls cap-dependent translation initiation.

bioRxiv : the preprint server for biology·2026
Same journal

When does additional information improve accuracy of RNA secondary structure prediction?

bioRxiv : the preprint server for biology·2026
Same journal

Normative brain-state trajectories reveal deviation from healthy aging in Alzheimer's disease.

bioRxiv : the preprint server for biology·2026
Same journal

Noradrenergic infraslow rhythm during sleep is the critical link between heart-rate dynamics and memory consolidation.

bioRxiv : the preprint server for biology·2026
查看所有相关文章

相关实验视频

Updated: Apr 29, 2026

A GPC3-targeting Bispecific Antibody, GPC3-S-Fab, with Potent Cytotoxicity
11:13

A GPC3-targeting Bispecific Antibody, GPC3-S-Fab, with Potent Cytotoxicity

Published on: July 12, 2018

8.7K

选择性双特异性EPO-R/CD131激动剂的合理设计

Kailyn E Doiron, Jeffrey C Way, Pamela A Silver

    bioRxiv : the preprint server for biology
    |September 5, 2025
    PubMed
    概括
    此摘要是机器生成的。

    这项研究模拟了红蛋白受体 (EPO-R) / CD131复合体,并开发了两种特异性蛋白质来选择性地激活它. 这些工程蛋白质成功地激活了EPO-R/CD131信号,提供了新的治疗途径.

    更多相关视频

    Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody
    07:36

    Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody

    Published on: May 16, 2020

    5.4K
    Tracking Bispecific Antibody-Induced T Cell Trafficking Using Luciferase-Transduced Human T Cells
    10:19

    Tracking Bispecific Antibody-Induced T Cell Trafficking Using Luciferase-Transduced Human T Cells

    Published on: May 12, 2023

    1.3K

    相关实验视频

    Last Updated: Apr 29, 2026

    A GPC3-targeting Bispecific Antibody, GPC3-S-Fab, with Potent Cytotoxicity
    11:13

    A GPC3-targeting Bispecific Antibody, GPC3-S-Fab, with Potent Cytotoxicity

    Published on: July 12, 2018

    8.7K
    Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody
    07:36

    Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody

    Published on: May 16, 2020

    5.4K
    Tracking Bispecific Antibody-Induced T Cell Trafficking Using Luciferase-Transduced Human T Cells
    10:19

    Tracking Bispecific Antibody-Induced T Cell Trafficking Using Luciferase-Transduced Human T Cells

    Published on: May 12, 2023

    1.3K

    科学领域:

    • 分子生物学
    • 结构生物学
    • 免疫学

    背景情况:

    • 通过血液细胞上的EPO受体 (EPO-R) 同位体 (EPO-R/EPO-R) 发出红色素 (EPO) 信号.
    • 通过非造血细胞的EPO-R/CD131异构体传递信号的理解很差,并且结构上没有特征.
    • 激活EPO-R/CD131提供了超越传统EPO应用的新疗法.

    研究的目的:

    • 阐明EPO-R/CD131复合体形成的结构基础.
    • 设计和验证选择性激活EPO-R/CD131信号的两种特定蛋白质.
    • 研究双特异性支架对细胞因子受体调节的潜力.

    主要方法:

    • 为EPO-R/CD131综合体构建一个结构模型.
    • 设计和合成各种形式的抗EPO-R和抗CD131双特异性蛋白质 (tandem scFv,双特异性抗体).
    • 作为对工程蛋白质反应EPO-R/CD131激活的读数,评估STAT5酸化.

    主要成果:

    • 已经成功生成了EPO-R/CD131综合体的结构模型.
    • 工程双特异性蛋白质,特别是双特异性scFv和双特异性抗体格式,选择性激活EPO-R/CD131信号.
    • 通过STAT5化证实了激活,与EPO-R/EPO-R接触不同.
    • 绑定域排列和链接器长度的修改影响了激活,与结构模型保持一致.

    结论:

    • 双特定蛋白质工程为选择性细胞因子受体激活提供了可行的策略.
    • 开发的双特异性蛋白质显示出强大的EPO-R/ CD131激动性.
    • 这项工作为进一步研究EPO-R/CD131的生物学及其治疗潜力奠定了基础.